AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21062541 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically informed sessions based on cognitive-behavioural therapy or person-centred counselling principles
Number of subjects: 30
Study 21062541 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the Edinburgh Postnatal Depression Scale (EPDS)
Number of subjects: 30
Study 21062541 — intervention group
Group type: EXPERIMENTAL
Intervention: Health visitor's support
Number of subjects: 30
Study 18430980 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological rehabilitation (NR) program in group NR (N=5)
Number of subjects: 16
Study 18430980 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized neuropsychological rehabilitation (NR) in individualized NR group (N=6)
Number of subjects: 16
Study 18430980 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological rehabilitation (NR) at home under supervision of a relative or caregiver (N=5)
Number of subjects: 16
Study 15157043 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO (G2)
Number of subjects: 27
Study 15157043 — intervention group
Group type: COMPARATOR
Intervention: Usual care (G1)
Number of subjects: 27
Study 11680947 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical lidocaine block
Number of subjects: 103
Study 11680947 — intervention group
Group type: COMPARATOR
Intervention: Vaginal application of Emla
Number of subjects: 103
Study 9043838 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 254
Study 9043838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 7936945 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive music
Number of subjects: 14
Study 7936945 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative music
Number of subjects: 14
Study 7936945 — intervention group
Group type: COMPARATOR
Intervention: White noise
Number of subjects: 14
Study 2851181 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 120 mg/m2 every 4 weeks and vindesine 3 mg/m2 weekly
Number of subjects: 201
Study 2851181 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 201
Study 2851181 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/vindesine (chemotherapy)
Number of subjects: 201
Study 2851181 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 201
Study 31993658 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress Tolerance Treatment (DT-W)
Number of subjects: 69
Study 31993658 — intervention group
Group type: COMPARATOR
Intervention: Smoking Health Education (HE)
Number of subjects: 69
Study 29471677 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused coping
Number of subjects: 288
Study 29471677 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-focused coping
Number of subjects: 288
Study 29471677 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater family support
Number of subjects: 288
Study 29471677 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher community support
Number of subjects: 288
Study 27030088 — intervention group
Group type: EXPERIMENTAL
Intervention: Liothyronine 15 μg for two weeks, then 30-45 μg for four weeks
Number of subjects: 0
Study 27030088 — intervention group
Group type: EXPERIMENTAL
Intervention: Liothyronine 30-45 μg
Number of subjects: 0
Study 27030088 — intervention group
Group type: EXPERIMENTAL
Intervention: Liothyronine therapy
Number of subjects: 0
Study 24913003 — intervention group
Group type: EXPERIMENTAL
Intervention: C-TraIn (multicomponent transitional care improvement program)
Number of subjects: 382
Study 24913003 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 382
Study 22646973 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 30
Study 22646973 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq(®) laryngoscope
Number of subjects: 30
Study 22646973 — intervention group
Group type: EXPERIMENTAL
Intervention: Storz DCI(®) laryngoscope
Number of subjects: 30
Study 22646973 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyrus Infant Bullard(®) laryngoscope
Number of subjects: 30
Study 20336804 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 46
Study 20336804 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 46
Study 18587249 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter‐assisted TURP
Number of subjects: 61
Study 18587249 — intervention group
Group type: COMPARATOR
Intervention: Traditional TURP
Number of subjects: 61
Study 15961567 — intervention group
Group type: EXPERIMENTAL
Intervention: Early headgear (HG) treatment initiated immediately
Number of subjects: 68
Study 15961567 — intervention group
Group type: COMPARATOR
Intervention: Control group with minor interceptive procedures
Number of subjects: 68
Study 15961567 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups underwent orthodontic therapy including fixed appliances and possible extractions when necessary
Number of subjects: 68
Study 15961567 — intervention group
Group type: EXPERIMENTAL
Intervention: Early headgear (HG) treatment
Number of subjects: 68
Study 11785738 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10233492 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (5 g/day)
Number of subjects: 50
Study 10233492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9119427 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care programme (early registration)
Number of subjects: 0
Study 9119427 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 1760424 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NEA) 1 mg + ethinyl oestradiol (EE) 50 micrograms
Number of subjects: 622
Study 1760424 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) 250 micrograms + EE 50 micrograms
Number of subjects: 622
Study 1760424 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG 250 micrograms + EE 30 micrograms
Number of subjects: 622
Study 1760424 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG 150 micrograms + EE 30 micrograms
Number of subjects: 622
Study 1760424 — intervention group
Group type: COMPARATOR
Intervention: Control group (155 women not receiving OC)
Number of subjects: 622
Study 6802085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 109
Study 6802085 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin plus cloxacillin
Number of subjects: 109
Study 30981629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (1000 mg, n = 86)
Number of subjects: 176
Study 30981629 — intervention group
Group type: COMPARATOR
Intervention: Oral iron (II) fumarate (100 tablets of 100 mg [10 per week], n = 90)
Number of subjects: 176
Study 31292107 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% BWSTT
Number of subjects: 30
Study 31292107 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% BWSTT
Number of subjects: 30
Study 31292107 — intervention group
Group type: COMPARATOR
Intervention: Unsupported TT (control group)
Number of subjects: 30
Study 28335000 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 25
Study 28335000 — intervention group
Group type: COMPARATOR
Intervention: Placebo feedback training (sham)
Number of subjects: 25
Study 26521922 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HFNO) for 2 hours
Number of subjects: 100
Study 26521922 — intervention group
Group type: COMPARATOR
Intervention: Venturi mask oxygen for 2 hours
Number of subjects: 100
Study 24123319 — intervention group
Group type: EXPERIMENTAL
Intervention: ASL MRI at 1.5T
Number of subjects: 98
Study 24123319 — intervention group
Group type: EXPERIMENTAL
Intervention: ASL MRI at 3T
Number of subjects: 98
Study 24123319 — intervention group
Group type: EXPERIMENTAL
Intervention: ASL MRI in group a (good/moderate function)
Number of subjects: 98
Study 24123319 — intervention group
Group type: COMPARATOR
Intervention: ASL MRI in group b (poor function)
Number of subjects: 98
Study 24123319 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of ASL perfusion with eGFR
Number of subjects: 98
Study 23095628 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapler group
Number of subjects: 337
Study 23095628 — intervention group
Group type: COMPARATOR
Intervention: Hand suture group
Number of subjects: 337
Study 19172098 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg) twice a week for 4 months
Number of subjects: 32
Study 19172098 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 patients with ED who did not take any treatment)
Number of subjects: 32
Study 17567687 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive interaction with a peer under stress, referral to medical or management staff if problems do not resolve.
Number of subjects: 142
Study 17567687 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting ideas of DSH.
Number of subjects: 142
Study 17567687 — intervention group
Group type: EXPERIMENTAL
Intervention: Active involvement in the care of peers and appropriate referral if the situation deteriorates.
Number of subjects: 142
Study 17567687 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of DSH as a medical problem requiring immediate intervention.
Number of subjects: 142
Study 17567687 — intervention group
Group type: EXPERIMENTAL
Intervention: Help seeking behavior regarding DSH.
Number of subjects: 142
Study 15710092 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (up to 3,600 mg/day)
Number of subjects: 30
Study 15710092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12213867 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide 30 mg
Number of subjects: 675
Study 12213867 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide 60 mg
Number of subjects: 675
Study 12213867 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide 120 mg
Number of subjects: 675
Study 12213867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 675
Study 12213867 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide (all doses)
Number of subjects: 675
Study 9823014 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucerna (50% fat)
Number of subjects: 32
Study 9823014 — intervention group
Group type: COMPARATOR
Intervention: Ensure with Fibre (30% fat)
Number of subjects: 32
Study 7864913 — intervention group
Group type: EXPERIMENTAL
Intervention: Active message designed to encourage giving up smoking
Number of subjects: 122
Study 7864913 — intervention group
Group type: COMPARATOR
Intervention: Control message (voice counting numbers)
Number of subjects: 122
Study 3781675 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, 40 mg t.i.d.
Number of subjects: 13
Study 3781675 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem, 60 mg t.i.d.
Number of subjects: 13
Study 3781675 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 13
Study 3781675 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 13
Study 30445922 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional telemonitoring, television messages, and dietary advice by a nurse or a dietician for 6 months
Number of subjects: 215
Study 30445922 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 215
Study 29231561 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongdu Rezhen method
Number of subjects: 68
Study 29231561 — intervention group
Group type: COMPARATOR
Intervention: Twirling‐reinforcing needling method
Number of subjects: 68
Study 24237386 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg once daily for 12 weeks
Number of subjects: 44
Study 24237386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 22726914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral smoking cessation treatment (CBT)
Number of subjects: 103
Study 22726914 — intervention group
Group type: COMPARATOR
Intervention: Autogenic training (Control Group)
Number of subjects: 103
Study 20592253 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 5 mg/day
Number of subjects: 208
Study 20592253 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 20 mg/day
Number of subjects: 208
Study 20592253 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 50 mg/day
Number of subjects: 208
Study 20592253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 19099943 — intervention group
Group type: EXPERIMENTAL
Intervention: DK crush technique
Number of subjects: 311
Study 19099943 — intervention group
Group type: COMPARATOR
Intervention: Classical crush technique (C)
Number of subjects: 311
Study 18824852 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pantoprazole infusion
Number of subjects: 0
Study 18824852 — intervention group
Group type: COMPARATOR
Intervention: Continuous pantoprazole infusion
Number of subjects: 0
Study 15197501 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-registered gated SPECT-CT images
Number of subjects: 23
Study 11307261 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (no leakage and slight leakage specimens immersed in methylene blue 2% for 24 h)
Number of subjects: 80
Study 11307261 — intervention group
Group type: COMPARATOR
Intervention: Group II (water-filled gaps immersed in methylene blue 2% for 24 h)
Number of subjects: 80
Study 11307261 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III (dry gaps with transport air applied, immersed in methylene blue 2% for 24 h)
Number of subjects: 80
Study 9091798 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (25 Gy delivered in five fractions in one week) followed by surgery
Number of subjects: 1168
Study 9091798 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1168
Study 9091798 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated with curative resection after preoperative irradiation
Number of subjects: 1168
Study 9091798 — intervention group
Group type: COMPARATOR
Intervention: Patients treated with curative resection after surgery alone
Number of subjects: 1168
Study 8458598 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Dopa (300 mg total: 50 mg at 9 am, 100 mg before lunch, 150 mg before dinner)
Number of subjects: 5
Study 8458598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 3752422 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg lormetazepam
Number of subjects: 20
Study 3752422 — intervention group
Group type: COMPARATOR
Intervention: 0.02 mg/kg flunitrazepam
Number of subjects: 20
Study 30666823 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab (10 mg/kg) plus azathioprine (2 mg/kg/day) and low-dose oral glucocorticoids (≤10 mg/day)
Number of subjects: 105
Study 30666823 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus azathioprine (2 mg/kg/day) and low-dose oral glucocorticoids (≤10 mg/day)
Number of subjects: 105
Study 30666823 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab (10 mg/kg)
Number of subjects: 105
Study 30666823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 30020423 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ketamine (0.006 mg/kg/min)
Number of subjects: 40
Study 30020423 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40
Study 26401633 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy (cooling vibration device)
Number of subjects: 70
Study 26401633 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 70
Study 25224317 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally tailored newsletters
Number of subjects: 881
Study 25224317 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced tailored newsletters
Number of subjects: 881
Study 25224317 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally tailored newsletters among those with autonomous communication preference
Number of subjects: 881
Study 25224317 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced tailored newsletters among those with autonomous communication preference
Number of subjects: 881
Study 25224317 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally tailored newsletters among those with directive communication preference
Number of subjects: 881
Study 25224317 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced tailored newsletters among those with directive communication preference
Number of subjects: 881
Study 22168398 — intervention group
Group type: COMPARATOR
Intervention: 0 mg bupropion
Number of subjects: 8
Study 22168398 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg bupropion
Number of subjects: 8
Study 22168398 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg bupropion
Number of subjects: 8
Study 22168398 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 8
Study 18846473 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential Cognitive Therapy (RCT)
Number of subjects: 80
Study 18846473 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential Interpersonal Therapy (RIPT)
Number of subjects: 80
Study 18846473 — intervention group
Group type: EXPERIMENTAL
Intervention: Common process factors
Number of subjects: 80
Study 17485628 — intervention group
Group type: EXPERIMENTAL
Intervention: Pityriasis rosea in black children
Number of subjects: 50
Study 15315717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg, single oral dose)
Number of subjects: 8
Study 15315717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/d, repeated dosing for 2 weeks)
Number of subjects: 8
Study 15315717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 11449834 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary pain treatment (MPT)
Number of subjects: 189
Study 11449834 — intervention group
Group type: COMPARATOR
Intervention: General practice (GP group)
Number of subjects: 189
Study 11449834 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (WL group)
Number of subjects: 189
Study 10399516 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg hyperbaric bupivacaine plus 25 micrograms fentanyl (0.5 ml) and cerebrospinal fluid (CSF) 0.6 ml (Group M + F)
Number of subjects: 30
Study 10399516 — intervention group
Group type: COMPARATOR
Intervention: 8 mg hyperbaric bupivacaine plus 0.5 ml of CSF (Group M)
Number of subjects: 30
Study 8002551 — intervention group
Group type: EXPERIMENTAL
Intervention: Overtraining group (OT); weight trained legs daily for 2 weeks with 100% 1 repetition maximum
Number of subjects: 17
Study 8002551 — intervention group
Group type: EXPERIMENTAL
Intervention: Overtraining group (OT); exercise-induced concentrations of epinephrine
Number of subjects: 17
Study 8002551 — intervention group
Group type: EXPERIMENTAL
Intervention: Overtraining group (OT); exercise-induced concentrations of norepinephrine
Number of subjects: 17
Study 8002551 — intervention group
Group type: COMPARATOR
Intervention: Control group; exercised 1 day/wk with low relative intensity (50% 1 repetition maximum)
Number of subjects: 17
Study 3244794 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg PLG i.v.
Number of subjects: 10
Study 3244794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29897022 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 143
Study 29897022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 27477844 — intervention group
Group type: EXPERIMENTAL
Intervention: GMZ2 vaccine (100μg adjuvanted with aluminum hydroxide)
Number of subjects: 1849
Study 27477844 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine (rabies)
Number of subjects: 1849
Study 27477844 — intervention group
Group type: EXPERIMENTAL
Intervention: GMZ2 vaccine
Number of subjects: 1849
Study 26376397 — intervention group
Group type: EXPERIMENTAL
Intervention: PRD (propofol/remifentanil/dexmedetomidine)
Number of subjects: 80
Study 26376397 — intervention group
Group type: COMPARATOR
Intervention: PRS (propofol/remifentanil/saline)
Number of subjects: 80
Study 23698199 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% levobupivacaine with 2 Mi g/ml fentanyl
Number of subjects: 50
Study 23698199 — intervention group
Group type: COMPARATOR
Intervention: 0.1% levobupivacaine with 2 Mi g/ml fentanyl
Number of subjects: 50
Study 20861739 — intervention group
Group type: EXPERIMENTAL
Intervention: ramelteon (8 mg/day)
Number of subjects: 21
Study 20861739 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study 17548076 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 2000 mg/day
Number of subjects: 63
Study 17548076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 17548076 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin and Placebo
Number of subjects: 63
Study 16972407 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 degree reverse Trendelenburg's position
Number of subjects: 40
Study 16972407 — intervention group
Group type: COMPARATOR
Intervention: Supine-horizontal position
Number of subjects: 40
Study 11821201 — intervention group
Group type: EXPERIMENTAL
Intervention: Axial length measurement using the prototype PCI instrument (ALM)
Number of subjects: 45
Study 11821201 — intervention group
Group type: COMPARATOR
Intervention: Axial length measurement using immersion ultrasound (IUS)
Number of subjects: 45
Study 9892876 — intervention group
Group type: EXPERIMENTAL
Intervention: pumaprazole (100 mg b.d.)
Number of subjects: 13
Study 9892876 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole (20 mg o.d.)
Number of subjects: 13
Study 9892876 — intervention group
Group type: COMPARATOR
Intervention: pumaprazole
Number of subjects: 13
Study 7735594 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 5 ppm
Number of subjects: 13
Study 2248835 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane 0.1 MAC
Number of subjects: 8
Study 2248835 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane 0.2 MAC
Number of subjects: 8
Study 2248835 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane 0.4 MAC
Number of subjects: 8
Study 2248835 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane 0.2 MAC and greater
Number of subjects: 8